ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 190

NLRP3 Gene Analysis for Patients with Schnitzler’s Syndrome

Cong-Qiu Chu1, Carrie R. Austin2, Trudy M. Doyle2, Kelley A. Goodwin2, Noha El Torgomen2, Regina Treudler3 and Tammy M. Martin4, 1Rheumatology, Oregon Health & Science Univ and Portland VA Medical Center, Portland, OR, 2Casey Eye Institute, Oregon Health & Science University, Portland, OR, 3Department of Dermatology, Venereology and Allergology, Universitätsklinikum Leipzig AöR, Leipzig, Germany, 4Ophthalmology/L467AD, Oregon Health & Science Univ, Portland, OR

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: genomics and inflammation

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Session Title: Miscellaneous Rheumatic and Inflammatory Diseases: Periodic Fever Syndromes

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Schnitzler’s syndrome is characterized by chronic urticaria, intermittent fever, arthralgia, bone pain, gammopathy and marked systemic inflammation. The striking response to IL-1 blockade suggests that Schnitzler’s syndrome is an IL-1 mediated condition of the expanding spectrum of systemic autoinflammatory disorders. However, the mechanism leading to the increased IL-1 activity has remained elusive. We aim to identify genetic predisposition in patients with Schnitzler’s syndrome.

Methods:

Genomic DNA was extracted from peripheral blood mononuclear cells from 4 patients with a clinical diagnosis of Schnitzler’s syndrome. DNA sequencing was performed in both directions of NLRP3 gene regions, including exon 3 which contains the majority of mutations associated with the cryopyrinopathies. Genetic data of patients was compared with the reference sequence for mutations.

Results:

Of the 4 patients with Schnitzler’s syndrome, 2 had classical findings of monoclonal IgM, kappa; one with polyclonal IgA; and one with polyclonal IgG and IgA. All of the 4 patients were refractory to non-biologic immunosuppressive treatment but achieved sustained clinical remission with daily use of anakinra. DNA sequence analysis of NLRP3 revealed a disease-associated mutation encoding the V198M substitution in the patient with polyclonal IgG and IgA. However, this mutation was not found in the other 3 patients. No other disease-associated mutations were identified in NLRP3 for this patient or in the other 3 patients.

Conclusion:

Genetic studies of Schnitzler’s syndrome have been scanty primarily due to the rarity of the condition and the results have been mixed. Our 4 patients consist of classical (2 cases) and atypical (2 cases) Schnitzler’s syndrome. The V198M mutation was found in one with atypical Schnitzler’s syndrome (polyclonal IgG and IgA). Interestingly, this mutation was previously reported in one patient with classical Schnitzler’s syndrome with monoclonal IgM, kappa (1). However, another genetic study on a patient with classical Schnitzler’s syndrome found no mutations in NLRP3 (2). The distinct feature of Schnitzler’s syndrome is its gammopathy which is poorly responsive to IL-1 blockade suggesting that IL-1 may not mediate the gammopathy. Complete analysis of NLRP3 exons and their flanking regions in this cohort is underway as disease-associated mutations outside of exon 3 have been reported and there may be as yet unknown mutations involved in this phenotype. The presence of an NLRP3 mutation in another patient with Schnitzler’s syndrome confirms the finding that this disorder is inflammasome-mediated.

References:

1. Loock J, Lamprecht P, Timmann C, Mrowietz U, Csernok E, Gross WL. Genetic predisposition (NLRP3 V198M mutation) for IL-1-mediated inflammation in a patient with Schnitzler syndrome. J Allergy Clin Immunol. 2010;125:500-2.

2. Ryan JG, de Koning HD, Beck LA, Booty MG, Kastner DL, Simon A. IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission. J Allergy Clin Immunol. 2008;121:260-2.


Disclosure:

C. Q. Chu,
None;

C. R. Austin,
None;

T. M. Doyle,
None;

K. A. Goodwin,
None;

N. El Torgomen,
None;

R. Treudler,
None;

T. M. Martin,
None.

  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nlrp3-gene-analysis-for-patients-with-schnitzlers-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.